已发表论文

使用表面经 CD133 适配体修饰的姜黄素纳米脂质体治疗前列腺癌

 

Authors Ma Q, Qian W, Tao W, Zhou Y, Xue B

Received 2 April 2019

Accepted for publication 11 October 2019

Published 28 November 2019 Volume 2019:13 Pages 4021—4033

DOI https://doi.org/10.2147/DDDT.S210949

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Amy Norman

Peer reviewer comments 2

Editor who approved publication: Dr Sukesh Voruganti

Aim: The aim of this study was to characterize curcumin (CUR)-loaded CD133 aptamer A15 liposomes for their antitumor activity in vitro and in vivo.
Methods: The modified CUR liposomes were prepared by the thin-film hydration technique.
Results: The particles showed spherical shape under electron microscopy with sizes 
Conclusion: These results indicate that A15 modified CUR liposomes are a promising candidate for antitumor drug delivery.
Keywords: CD133 aptamers, curcumin, prostate cancer, liposomes, cell viability, cellular internalization, in vivo evaluation




Figure 1 The basic structure of aptamer A15 modified CUR liposomes.